Application 209139
- Type
- NDA
- Sponsor
- CARMEL BIOSCIENCES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 20MG/5ML | Yes | No |
| 002 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 80MG/20ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209139-001 | PREXXARTAN | VALSARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N209139-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | AB | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan | VALSARTAN | A-S Medication Solutions | d9af6ba1-c760-4af6-b733-88e4892d4cb6 | 2026-01-23 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | AvKARE | a8c61488-4219-dfcb-e053-2a95a90a98a4 | 2026-01-16 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | f2b77f2f-333e-f3e3-e053-2a95a90a1fa7 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | f305e9d7-341a-45f6-e053-2a95a90a2d69 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | f756009f-f04f-6518-e053-6294a90a79ed | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Northwind Health Company, LLC | 03af7d09-314a-fe85-e063-6294a90afa25 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | Northwind Health Company, LLC | db4801e5-6e0f-2cb3-e053-2995a90a709a | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Ascend Laboratories, LLC | 7b4ecaf9-e84c-4660-9cd1-65a238efd8a8 | 2025-12-17 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Coupler LLC | 3eee9505-ebba-76e3-e063-6294a90acd6e | 2025-09-16 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Coupler LLC | 3dfe5407-96a6-d2f4-e063-6294a90aa810 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Solco Healthcare US, LLC | 26080940-bcd3-446d-9026-3ddfb58e281e | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Dr. Reddy's Laboratories Limited | 75235313-8a07-8849-9b5a-12887992033e | 2025-08-21 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | PD-Rx Pharmaceuticals, Inc. | 5afd7c3d-c66b-479c-bfd0-6c04658b157d | 2025-04-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Proficient Rx LP | f59f71d3-c143-43e5-ac22-0b1d741f4a81 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| VALSARTAN | VALSARTAN | Direct_Rx | 946692f5-0fe2-89b7-e053-2995a90a4d91 | 2025-01-27 | Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Camber Pharmaceuticals, Inc. | 0ff36e83-b307-42db-a2ab-bae3f6805c20 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | AvPAK | 0878f27e-5368-c93f-e063-6394a90a1086 | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | A-S Medication Solutions | 2847db2a-fcc9-4776-875a-ba6d57d5ea8b | 2024-10-16 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | American Health Packaging | 7ea2fdf1-4fda-47a7-8110-62fb6468c989 | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Viona Pharmaceuticals Inc | bd7b35c7-9f01-4afd-b497-bbe0f3d69b29 | 2024-07-23 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25208-100 | PREXXARTAN | PREXXARTAN | Medicure International Inc. | NDA | Current |